EE400 Cost-Effectiveness Analysis of Fampridine for Multiple Sclerosis Treatment in China

Abstract

Authors

X Zhao H Yang J Zhao T Wei J Liu

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×